NEW YORK – Fit4D’s focus on tech-enabled diabetes management is paying off for founder and CEO David Weingard, who has been named one of 10 finalists for the Lyfebulb-Novo Nordisk Innovation Award.
“The reward for me is that we’re changing the diabetes space,” Weingard said.
The award spotlights outstanding patient entrepreneurs’ efforts and ideas to better manage diabetes through consumer products, medical devices or health care information technology. The winner of this year’s award will be announced on Dec. 7 at the Novo Nordisk Innovation Summit in Copenhagen, Denmark.
Fit4D is a technology-enabled health coaching solution that scales the reach of expert diabetes educators, allowing them to manage a patient population more than five times larger than traditional inpatient settings. The company’s clients include pharmaceutical companies with a branded drug or device seeking to improve initiation and adherence, and payers looking to improve health outcomes and quality measures.
“No one had figured out how to do this affordably until us,” said Weingard. “We figured out how to scale the human touch of the diabetes experience.”
Fit4D’s team of Certified Diabetes Educators across the country leverage the company’s proprietary technology platform to engage patients with a personalized plan that addresses individual barriers they face when learning to self-manage their diabetes. The CDEs communicate with the patients through phone calls, texts and emails. Coaching topics include basic diabetes information, tips and tactics to initiate therapy and improve medication adherence, preventive care, nutrition, fitness and advice.
Weingard said that home health care agencies are great partners for Fit4D because they are in the home with the patient.
“They have that real-time knowledge of the patient, but they might not have the expert diabetes knowledge,” Weingard said. “Patients need someone who is trained, and that’s what we do. We’re a virtual extension of what the home health worker is doing.”